Cargando…

Mutational mechanisms of EZH2 inactivation in myeloid neoplasms

EZH2, a component of the polycomb repressive complex 2, catalyses the trimethylation of histone H3 lysine 27, a chromatin mark associated with transcriptional repression. EZH2 loss-of-function mutations are seen in myeloid neoplasms and are associated with an adverse prognosis. Missense mutations in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chase, Andrew, Score, Joannah, Lin, Feng, Bryant, Catherine, Waghorn, Katherine, Yapp, Sarah, Carreno-Tarragona, Gonzalo, Aranaz, Paula, Villasante, Aranzazu, Ernst, Thomas, Cross, Nicholas C. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610374/ https://www.ncbi.nlm.nih.gov/pubmed/32322039 http://dx.doi.org/10.1038/s41375-020-0816-y

Ejemplares similares

Should we move to a genomic classification of neutrophilic myeloid neoplasms?
por: Carreño-Tarragona, Gonzalo, et al.
Publicado: (2023)

EZH2 in Myeloid Malignancies
por: Rinke, Jenny, et al.
Publicado: (2020)

Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia
por: Jawhar, Mohamad, et al.
Publicado: (2017)

EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity
por: Berg, Johannes Lorenz, et al.
Publicado: (2021)

PRR14L mutations are associated with chromosome 22 acquired uniparental disomy, age related clonal hematopoiesis and myeloid neoplasia
por: Chase, Andrew, et al.
Publicado: (2018)

Mutations in EZH2 are associated with poor prognosis for patients with myeloid neoplasms
por: Zhang, Qi, et al.
Publicado: (2019)

Megalencephaly Syndromes: Exome Pipeline Strategies for Detecting Low-Level Mosaic Mutations
por: Tapper, William J., et al.
Publicado: (2014)

Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia
por: Cross, Nicholas C. P., et al.
Publicado: (2018)

P747: CLINICAL CHARACTERISTICS AND OUTCOME OF EZH2-MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE
por: Oum, Muhamad, et al.
Publicado: (2023)

Multidisciplinary management in chronic myeloid leukemia improves cardiovascular risk measured by SCORE
por: Blanco Sánchez, Alberto, et al.
Publicado: (2023)

Dual roles of EZH2 in acute myeloid leukemia
por: Skoda, Radek C., et al.
Publicado: (2019)

Myeloid Ezh2 Deficiency Limits Atherosclerosis Development
por: Neele, Annette E., et al.
Publicado: (2021)

Clinical Significance of EZH2 in Acute Myeloid Leukemia
por: Jiao, Weiyun, et al.
Publicado: (2022)

Retracted: Clinical Significance of EZH2 in Acute Myeloid Leukemia
por: Intelligence and Neuroscience, Computational
Publicado: (2023)

Co-occurrence of myeloid neoplasm and plasma cell neoplasm
por: Jum’ah, Husam, et al.
Publicado: (2022)

Extracellular Vesicles in Myeloid Neoplasms
por: Karantanou, Christina, et al.
Publicado: (2022)

International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms
por: Gianelli, Umberto, et al.
Publicado: (2022)

EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs)
por: April-Monn, Simon Leonhard, et al.
Publicado: (2021)

Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature
por: De Luca-Johnson, Javier, et al.
Publicado: (2016)

Myeloproliferative neoplasms
por: Cross, Nick
Publicado: (2019)

Myeloid Neoplasms in the Guise of Nutritional Deficiency
por: Parthasarathy, Veda
Publicado: (2012)

Pegylated liposomal doxorubicin for myeloid neoplasms
por: Zhang, Cheng, et al.
Publicado: (2019)

Bone marrow niches in myeloid neoplasms
por: Kitagawa, Masanobu, et al.
Publicado: (2019)

Editorial: Immunologic Mechanisms of Myeloid Neoplasms
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Monitoring of clonal evolution of acute myeloid leukemia identifies the leukemia subtype, clinical outcome and potential new drug targets for post-remission strategies or relapse
por: Onecha, Esther, et al.
Publicado: (2020)

IGF2BP1 Promotes Proliferation of Neuroendocrine Neoplasms by Post-Transcriptional Enhancement of EZH2
por: Sperling, Florian, et al.
Publicado: (2022)

Posttranslational splicing modifications as a key mechanism in cytarabine resistance in acute myeloid leukemia
por: Morales, María Luz, et al.
Publicado: (2023)

Ezh2 is essential for the generation of functional yolk sac derived erythro-myeloid progenitors
por: Neo, Wen Hao, et al.
Publicado: (2021)

Expression of Enhancer of Zeste Homolog 2 (EZH2) Gene in Acute Myeloid Leukemia
por: Hamed, Nahla A. M., et al.
Publicado: (2023)

Isolated Orbital Myeloid Sarcoma as a Therapy-related Myeloid Neoplasm
por: Ishiguro, Kazuya, et al.
Publicado: (2018)

Myeloid/lymphoid neoplasm with eosinophilia and rearrangement of PDGFRA presenting as myeloid sarcoma
por: Barouqa, Mohammad, et al.
Publicado: (2022)

Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation
por: Lv, Qi, et al.
Publicado: (2021)

Loss of Ezh2 synergizes with JAK2-V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis
por: Shimizu, Takafumi, et al.
Publicado: (2016)

Therapy-related myeloid neoplasms in children and adolescents
por: Cho, Hee Won, et al.
Publicado: (2016)

GATA2 deficiency and related myeloid neoplasms
por: Wlodarski, Marcin W., et al.
Publicado: (2017)

Therapy-related myeloid neoplasms: clinical perspectives
por: Fianchi, Luana, et al.
Publicado: (2018)

Molecular Pathogenesis in Myeloid Neoplasms with Germline Predisposition
por: Gao, Juehua, et al.
Publicado: (2021)

Complex Landscape of Alternative Splicing in Myeloid Neoplasms
por: Hershberger, Courtney E., et al.
Publicado: (2020)

DDX41-associated susceptibility to myeloid neoplasms
por: Makishima, Hideki, et al.
Publicado: (2023)

The role of EZH1 and EZH2 in development and cancer
por: Lee, Soo Hyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s82cvv0ao3luq73orfbmlmf8al